No Prosecution In South Korean Co.'s Transfer Pricing Row
South Korean regulators said they will not seek to prosecute a major biopharmaceutical company for running afoul of the country's regulations on transfer pricing, according to local media....To view the full article, register now.
Already a subscriber? Click here to view full article